Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 26 May 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Minimally invasive hepatic surgery is a viable alternative to open surgery

In the most recent issue of the Annals of Surgery, a team of doctors report on their experience with more than 500 minimally invasive hepatic procedures.

News image

fiogf49gjkf04

Recent data have confirmed the safety and efficacy of minimally invasive liver surgery.

Despite these reports, no programmatic approach to minimally invasive liver surgery has been proposed.

Dr Joseph Buell and colleagues evaluated more than 500 minimally invasive hepatic procedures.

The team retrospectively reviewed all patients who underwent a minimally invasive procedure for the management of hepatic tumors between 2001 and 2008.

Patients were divided into 3 groups.

Group 1 included laparoscopy with intraoperative ultrasound and biopsy only, Group 2 evaluated laparoscopic radiofrequency ablation, and minimally invasive resection was assessed in Group 3.

Conversion rates to open surgery for the resection group were 2%
Annals of Surgery

The team compared the various forms of surgery, the incidence of complications, tumor recurrence, mortality, and cost.

Statistical analysis was performed using chi-squared analysis, Student t test, Kaplan-Meier survival analysis with the log-rank test, and multivariable Cox models.

The researchers performed a total of 590 minimally invasive hepatic procedures during 489 operative interventions.

The representative tumor histologies included hepatocellular carcinoma, colorectal carcinoma, miscellaneous liver metastases, biliary cancer, and benign tumors.

The team found 35 patients underwent laparoscopic ultrasound and confirmatory biopsy alone, 201 patients underwent 240 laparoscopic radiofrequency ablations, and 253 patients underwent 306 minimally invasive resections.

Conversion rates to open surgery for the radiofrequency ablation and resection group were 2% overall.

The team noted that 41% patients were cirrhotic, of which 31 resections were performed in cirrhotic patients.

The research team observed complication and mortality rates for radiofrequency ablation and resection were comparable.

However, complication rates and mortality rates were higher in the cirrhotic versus noncirrhotic resection group.

Overall recurrence rates for radiofrequency ablation and resection groups were 24% and 23%, respectively.

The researchers found that local recurrence rates were higher in the radiofrequency ablation group.

The team found overall patient survival differed between hepatocellular carcinoma patients receiving radiofrequency ablation alone and those receiving radiofrequency ablation and orthotropic liver transplantation.

Overall survival for cancer patients receiving radiofrequency ablation versus resection differed significantly when unadjusted for other covariates, and remained marginally significant in a multivariable model.

Dr Buell‘s team concluded, “Minimally invasive hepatic surgery has become a viable alternative to open hepatic surgery.”

“Our present data are equivalent or superior to those encountered in any large open series.”

“Our experience with radiofrequency ablation confirms a low local recurrence rate and an excellent technique for bridging patients to transplantation.”

“Morbidity and mortality rates for minimally invasive hepatic resections in cirrhotics, is similar to other reported open resection series.”

“This series confirmed excellent interim survival rates after laparoscopy and superiority over radiofrequency ablation in the treatment of cancer, with significantly lower local tumor recurrence rate.”

 

Annals of Surgery 2008: 248(3): 475-86


18 September 2008

Go to top of page Email this page Email this page to a colleague

 25 May 2018 
Colorectal cancer–specific mortality
 25 May 2018 
Technology to increase colorectal cancer screening
 25 May 2018 
Post‐operative complications in elderly IBD
 24 May 2018 
Patient-reported outcome measures in IBD trials
 24 May 2018 
Alcohol consumption and outcomes in drug-induced liver injury
 24 May 2018 
Precision medicine for tumors
 23 May 2018 
Management of perianal fistulas in Crohn’s disease
 23 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 23 May 2018 
High body mass index is and ulcerative colitis
 22 May 2018 
Worldwide H.pylori prevalence
 22 May 2018 
PPI and risk of stroke
 22 May 2018 
Online tool predicts bowel dysfunction severity prior to anterior resection
 21 May 2018 
Depressive symptoms in IBD youth
 21 May 2018 
PPI use and cognitive decline
 21 May 2018 
Fecal incontinence and quality of life in IBD
 18 May 2018 
Esophageal dilatation in clinical practice 
 17 May 2018 
IBD and later extraintestinal manifestations
 17 May 2018 
Repeat stool DNA testing
 17 May 2018 
IBS and chronic fatigue following GI infection
 16 May 2018 
Factors associated with fecal incontinence
 16 May 2018 
Diagnostic delay in Crohn's disease
 16 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 15 May 2018 
Guidelines for management of Crohn's
 15 May 2018 
Hep B in the Grey Zone
 15 May 2018 
New therapies for CDI
 14 May 2018 
Blood test for the diagnosis of fibrotic NASH
 14 May 2018 
Outcomes at bariatric centers of excellence
 14 May 2018 
Management of perianal fistulas in Crohn’s
 11 May 2018 
Detection of undiagnosed celiac disease
 11 May 2018 
Alcohol consumption and drug-induced liver injury
 10 May 2018 
Colorectal cancer screening
 10 May 2018 
Fibrosis in patients with chronic hepatitis B
 09 May 2018 
Fecal incontinence
 09 May 2018 
Health problems and IBS
 09 May 2018 
Esophageal dilatation in clinical practice 
 07 May 2018 
Omitting antibiotics in uncomplicated acute diverticulitis
 07 May 2018 
Health problems and IBS
 07 May 2018 
Assessment of diminutive colorectal polyps
 04 May 2018 
National Institutes of Health workshop and obesity
 04 May 2018 
Factors associated with fecal incontinence
 04 May 2018 
Colorectal cancer screening and ethnic inequities
 03 May 2018 
Gastrointestinal ultrasound in IBD
 03 May 2018 
Ultransonography in postsurgical recurrence in Crohn's
 02 May 2018 
Symptom assessment in cirrhotic ascites
 02 May 2018 
Hep C antiviral treatment and liver cancer risk
 02 May 2018 
Chronic Hep B
 01 May 2018 
European guidelines on pancreatic cystic neoplasms
 01 May 2018 
Interferon‐free regimens in Hep C
 01 May 2018 
Age at IBD onset and extraintestinal complications
 30 April 2018 
Formula for preterm infants
 30 April 2018 
Primary antibiotic resistance and sequential therapy for H. pylori
 27 April 2018 
Eastern and western practices for endoscopic resection of colorectal lesions
 27 April 2018 
Anxiety scale for chronic esophageal disease
 27 April 2018 
Disease activity in eosinophilic esophagitis
 26 April 2018 
Obesity and physical activity in diverticulosis
 26 April 2018 
Primary sclerosing cholangitis in the USA
 25 April 2018 
Aspirin and pancreatic cancer
 25 April 2018 
Central mediators of irinotecan-induced steatohepatitis
 25 April 2018 
Neuroimaging in Hep C
 24 April 2018 
Scoring system identifies cancer risk in Barrett's

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us